OraSure Technologies (FRA:EP3) Total Liabilities : €37.6 Mil (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is OraSure Technologies Total Liabilities?

OraSure Technologies's Total Liabilities for the quarter that ended in Jun. 2024 was €37.6 Mil.

OraSure Technologies's quarterly Total Liabilities declined from Dec. 2023 (€47.84 Mil) to Mar. 2024 (€38.00 Mil) and declined from Mar. 2024 (€38.00 Mil) to Jun. 2024 (€37.63 Mil).

OraSure Technologies's annual Total Liabilities increased from Dec. 2021 (€71.20 Mil) to Dec. 2022 (€75.29 Mil) but then declined from Dec. 2022 (€75.29 Mil) to Dec. 2023 (€47.84 Mil).

OraSure Technologies Total Liabilities Historical Data

The historical data trend for OraSure Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OraSure Technologies Total Liabilities Chart

OraSure Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

37.94

45.95

71.20

75.29

47.84

OraSure Technologies Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Liabilities	Get a 7-Day Free Trial															54.88	50.17	47.84	38.00	37.63

OraSure Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

OraSure Technologies's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	36.255	+	(10.443	+	0.638
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.508	+	0)
	=	47.8

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	442.769	-	394.925
	=	47.8

OraSure Technologies's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	26.804	+	(9.755	+	0.486
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.582	+	0)
	=	37.6

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	433.233	-	395.605
	=	37.6

OraSure Technologies Total Liabilities Related Terms

Thank you for viewing the detailed overview of OraSure Technologies's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

OraSure Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OraSure Technologies Inc (FRA:EP3) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

OSUR:USA

Address

220 East First Street, Bethlehem, PA, USA, 18015

Website

https://www.orasure.com

OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

OraSure Technologies Headlines

No Headlines